Award facts
Completion date
65% complete
Aug 31, 2030
Originally Jun 30, 2024
Funding
$174,220,823.00 Federal
$10,224,956.00
Non-federal
Place of performance
Rochester, MN 55905, USA
Award details come from USAspending.gov.
Transactions
Action
Obligated
Date
Amendment
$540
Aug 14, 2026
Amendment
$0
Aug 13, 2026
Amendment
$0
Aug 13, 2026
Amendment
$123,012
Aug 13, 2026
Amendment
$451,127
Aug 12, 2026
Amendment
$284,525
Aug 11, 2026
Amendment
$18,718,786
Jul 31, 2026
Amendment
$0
Jun 18, 2026
Amendment
$0
Jun 18, 2026
Amendment
$0
Jun 2, 2026
Amendment
$0
Jun 2, 2026
Amendment
$0
Jun 2, 2026
Amendment
$0
Jun 2, 2026
Amendment
$0
Jun 2, 2026
Amendment
$0
Jun 2, 2026
Amendment
$0
Jun 2, 2026
Amendment
$0
Jun 2, 2026
Amendment
$0
Jun 2, 2026
Amendment
$0
May 20, 2026
Amendment
$0
May 20, 2026
Amendment
$0
May 20, 2026
Amendment
$0
May 20, 2026
Amendment
$0
May 20, 2026
Amendment
$0
May 20, 2026
Amendment
$0
May 20, 2026
Amendment
$0
May 20, 2026
Amendment
$61,400
May 20, 2026
Amendment
$0
May 20, 2026
Amendment
$0
May 20, 2026
Amendment
$61,400
May 20, 2026
Amendment
$0
May 20, 2026
Amendment
$0
May 20, 2026
Amendment
$61,400
May 20, 2026
Amendment
$0
Mar 17, 2026
Amendment
Artfl lefftds longitudinal frontotemporal lobar degeneration, cycle 2 (ALLFTD2)
$0
Mar 17, 2026
Amendment
$0
Mar 17, 2026
Amendment
$0
Mar 17, 2026
Amendment
$89,338
Sep 15, 2025
Amendment
$89,338
Sep 15, 2025
Amendment
$89,338
Sep 15, 2025
Amendment
$174,552
Sep 12, 2025
Amendment
$331,127
Sep 12, 2025
Amendment
$123,012
Sep 12, 2025
Amendment
$123,012
Sep 12, 2025
Amendment
$174,552
Sep 12, 2025
Amendment
$174,552
Sep 12, 2025
Amendment
$331,127
Sep 12, 2025
Amendment
$331,127
Sep 12, 2025
Amendment
$123,012
Sep 12, 2025
Amendment
Artfl lefftds longitudinal frontotemporal lobar degeneration, cycle 2 (ALLFTD2)
$16,947,844
Sep 9, 2025
Subawards
Subrecipient
Amount
Awarded
The Washington University
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2) - Administrative Core
$49,930
Sep 30, 2026
The Trustees Of The University Of Pennsylvania
$49,786
Sep 16, 2026
University Of Miami
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2) - Biofluid Core
$877,696
Jun 24, 2026
Emory University
$91,435
Jun 11, 2026
The General Hospital Corporation
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2) - Clinical Core
$947,726
Jun 3, 2026
The General Hospital Corporation
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2) - Administrative Core
$67,480
May 26, 2026
Vanderbilt University Medical Center
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2) - Clinical Core
$1,044,313
May 3, 2026
Brown University
$354,888
Apr 30, 2026
University Of California, San Diego
$82,950
Apr 21, 2026
Icahn School Of Medicine At Mount Sinai
$160,550
Apr 16, 2026
Trustees Of Indiana University
$142,650
Mar 31, 2026
University Of Alabama At Birmingham
$70,538
Mar 11, 2026
The Johns Hopkins University
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2) - Administrative Core
$179,198
Mar 6, 2026
Vlaams Instituut Voor Biotechnologie - Flanders Institute For Biotechnology
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2) - VIB Belgium
$123,012
Mar 5, 2026
Case Western Reserve University
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2) - Clinical Core
$76,475
Feb 26, 2026
The Trustees Of Columbia University In The City Of New York
$296,100
Feb 24, 2026
University Of North Carolina At Chapel Hill
$216,812
Feb 20, 2026
University Of California, LOS Angeles
$78,500
Feb 18, 2026
University Of Southern California
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2) - Neuroimaging Core
$218,300
Feb 16, 2026
The University Of Texas Health Science Center At San Antonio
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2) - Clinical Core
$212,625
Feb 11, 2026
The Trustees Of The University Of Pennsylvania
$1,002,219
Feb 6, 2026
Trustees Of Indiana University
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2) - Biofluid Core
$1,353,670
Feb 6, 2026
Northwestern University
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2) - Clinical Core
$76,000
Jan 30, 2026
University Of California, LOS Angeles
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2) - Genetics Core
$419,849
Jan 29, 2026
The Johns Hopkins University
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2) - Clinical Core
$255,859
Jan 23, 2026
The Methodist Hospital Research Institute
$996,051
Jan 22, 2026
The Regents Of The University Of California. San Francisco
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2) - Neuropathology Core
$496,797
Jan 21, 2026
The Regents Of The University Of California. San Francisco
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)
$6,257,075
Jan 20, 2026
Emory University
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2) - Clinical Core
$148,675
Jan 15, 2026
The FTD Disorders Registry. Llc
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2) - Administrative Core
$754,762
Jan 13, 2026
University Of Washington
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2) - Clinical Core
$143,838
Jan 13, 2026
The Regents Of The University Of Colorado
$177,450
Jan 13, 2026
The Methodist Hospital Research Institute
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2) - Project 1
$43,771
Jan 13, 2026
The FTD Disorders Registry. Llc
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2) - TRAC Core
$281,765
Jan 13, 2026
The Washington University
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2) - Clinical Core
$367,200
Jan 8, 2026
Regents Of The University Of Michigan
$146,738
Dec 22, 2025
University Health Network
This agreement is meant to cover the personnel effort associated with conducting approximately 10 Longitudinal Arm and 10 Biofluid Focused Arm visits per…
$5,239
Oct 21, 2025
University Of Washington
Statement of Work—Clinical Core 1. Site must have in place a team of qualified study staff, which includes (at a minimum) a study coordinator, neuropsychologist…
$21,620
Sep 5, 2025
The Methodist Hospital Research Institute
Statement of Work—Clinical Core 1. Site must have in place a team of qualified study staff, which includes (at a minimum) a study coordinator, neuropsychologist…
$48,500
Sep 4, 2025
The Trustees Of Columbia University In The City Of New York
We seek to model successful initiatives in other neurodegenerative disorders and expand our efforts in Advancing Research in Frontotemporal Lobar Degeneration…
$236,100
Jan 30, 2025
University Of Southern California
$92,572
Dec 5, 2024
The Regents Of The University Of California. San Francisco
$2,496,027
Dec 5, 2024
University Health Network
$28,369
Nov 1, 2024
Regents Of The University Of Michigan
$101,763
Oct 2, 2024
Vanderbilt University Medical Center
$346,000
Sep 18, 2024
The Johns Hopkins University
$325,305
Sep 10, 2024
The General Hospital Corporation
$389,958
Sep 6, 2024
Case Western Reserve University
$57,475
Aug 29, 2024
The Methodist Hospital Research Institute
$319,314
Aug 20, 2024
The FTD Disorders Registry. Llc
$253,750
Aug 19, 2024
Quick answers
Who received award U19AG063911?
U19AG063911 was awarded to Mayo Clinic by National Institute on Aging (National Institutes of Health) on September 15, 2019.
How much is award U19AG063911 worth?
$184,445,779 has been obligated on U19AG063911: $174,220,823 in federal funding and $10,224,956 in non-federal funding.
On GovTribe
See this award's full record
Every transaction and subaward
The recipient's other awards and teaming partners
Similar grant awards
Ask GovTribe AI about this award